ImmuPharma plc (LON:IMM – Get Free Report) rose 5.5% during mid-day trading on Tuesday . The stock traded as high as GBX 4.79 and last traded at GBX 4.39. Approximately 76,204 shares changed hands during trading, a decline of 98% from the average daily volume of 3,206,960 shares. The stock had previously closed at GBX 4.16.
ImmuPharma Stock Performance
The company’s 50-day moving average is GBX 5.63 and its 200-day moving average is GBX 7.09. The firm has a market cap of £26.83 million, a price-to-earnings ratio of -4.83 and a beta of 3.18.
About ImmuPharma
ImmuPharma PLC (LSE AIM: IMM) is a specialty biopharmaceutical company that discovers and develops peptide-based therapeutics. The Company’s portfolio includes novel peptide therapeutics for autoimmune diseases and anti-infectives. The lead program, P140 (Lupuzor™), is a first-in class autophagy immunomodulator for the treatment of Lupus and preclinical analysis suggest therapeutic activity for many other autoimmune diseases that share the same autophagy mechanism of action.
Recommended Stories
Receive News & Ratings for ImmuPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmuPharma and related companies with MarketBeat.com's FREE daily email newsletter.
